Free Trial

Virtu Financial LLC Has $212,000 Stock Holdings in Nutrien Ltd. (NYSE:NTR)

Nutrien logo with Basic Materials background

Key Points

  • Virtu Financial LLC significantly decreased its holdings in Nutrien Ltd. by 55.6%, now owning 4,263 shares valued at approximately $212,000.
  • Several major institutional investors increased their stakes in Nutrien, with JPMorgan Chase & Co. raising its position by 48.7% and Allianz Asset Management increasing by an astounding 789.0%.
  • Nutrien reported strong quarterly earnings of $2.65 per share, surpassing expectations, while also announcing a quarterly dividend of $0.545 to be paid on October 17th.
  • Need better tools to track Nutrien? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Virtu Financial LLC decreased its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 55.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,263 shares of the company's stock after selling 5,344 shares during the period. Virtu Financial LLC's holdings in Nutrien were worth $212,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in NTR. JPMorgan Chase & Co. increased its position in Nutrien by 48.7% during the 1st quarter. JPMorgan Chase & Co. now owns 6,992,535 shares of the company's stock worth $347,319,000 after buying an additional 2,291,518 shares during the period. Vanguard Group Inc. increased its position in Nutrien by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company's stock worth $1,051,709,000 after buying an additional 1,412,503 shares during the period. Barclays PLC increased its position in Nutrien by 192.7% during the 4th quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after buying an additional 854,543 shares during the period. Deutsche Bank AG increased its position in Nutrien by 11.3% during the 4th quarter. Deutsche Bank AG now owns 7,105,057 shares of the company's stock worth $317,951,000 after buying an additional 721,935 shares during the period. Finally, Allianz Asset Management GmbH increased its position in Nutrien by 789.0% during the 1st quarter. Allianz Asset Management GmbH now owns 659,150 shares of the company's stock worth $32,709,000 after buying an additional 585,002 shares during the period. Institutional investors own 63.10% of the company's stock.

Wall Street Analysts Forecast Growth

NTR has been the topic of several recent research reports. TD Securities increased their price objective on Nutrien from $70.00 to $72.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Scotiabank lowered their price objective on Nutrien from $62.00 to $60.00 and set a "sector perform" rating on the stock in a research report on Monday, August 11th. UBS Group lowered their price objective on Nutrien from $64.00 to $63.00 and set a "neutral" rating on the stock in a research report on Thursday, August 7th. Royal Bank Of Canada reiterated an "outperform" rating on shares of Nutrien in a research report on Monday, July 14th. Finally, Jefferies Financial Group restated a "hold" rating and issued a $66.00 price target (up previously from $63.00) on shares of Nutrien in a research report on Friday, July 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $62.65.

Read Our Latest Analysis on Nutrien

Nutrien Stock Performance

NYSE:NTR opened at $57.10 on Friday. The stock's 50-day simple moving average is $59.57 and its 200 day simple moving average is $55.51. The firm has a market capitalization of $27.80 billion, a PE ratio of 20.47, a price-to-earnings-growth ratio of 0.98 and a beta of 0.81. The company has a quick ratio of 0.85, a current ratio of 1.33 and a debt-to-equity ratio of 0.39. Nutrien Ltd. has a twelve month low of $43.69 and a twelve month high of $65.08.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, beating the consensus estimate of $2.41 by $0.24. The business had revenue of $10.30 billion for the quarter, compared to analyst estimates of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%. Nutrien's revenue was up 2.8% compared to the same quarter last year. During the same period last year, the firm posted $2.34 earnings per share. On average, analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Monday, September 29th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Monday, September 29th. This represents a $2.18 annualized dividend and a yield of 3.8%. Nutrien's dividend payout ratio (DPR) is 78.14%.

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines